{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:56:54Z","timestamp":1790355414491,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00347-008-1699-x","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T07:54:39Z","timestamp":1205222079000},"page":"285-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Schleimhautpemphigoid mit okul\u00e4rer Beteiligung","Mucous membrane pemphigoid with ocular involvement"],"prefix":"10.1007","volume":"105","author":[{"given":"E.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Meyer-ter-Vehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Geerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,13]]},"reference":[{"key":"1699_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1167\/iovs.02-0181","volume":"44","author":"Argueso","year":"2003","unstructured":"Argueso P, Tisdale A, Mandel U et al. (2003) The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci 44: 86\u201392","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1699_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/1523-1747.ep12329728","volume":"106","author":"Balding","year":"1996","unstructured":"Balding SD, Prost C, Diaz LA et al. (1996) Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106: 141\u2013146","journal-title":"J Invest Dermatol"},{"key":"1699_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.0022-202X.2005.23646.x","volume":"124","author":"Bekou","year":"2005","unstructured":"Bekou V, Thoma-Uszynski S, Wendler O et al. (2005) Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA. J Invest Dermatol 124: 732\u2013740","journal-title":"J Invest Dermatol"},{"key":"1699_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/BF00181996","volume":"232","author":"Bernauer","year":"1994","unstructured":"Bernauer W, Elder MJ, Leonard JN et al. (1994) The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation. Graefes Arch Clin Exp Ophthalmol 232: 533\u2013537","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1699_CR5","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.165.5.2824","volume":"165","author":"Bhol","year":"2000","unstructured":"Bhol KC, Dans MJ, Simmons RK et al. (2000) The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4. J Immunol 165: 2824\u20132829","journal-title":"J Immunol"},{"key":"1699_CR6","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1177\/00220345010800080601","volume":"80","author":"Bhol","year":"2001","unstructured":"Bhol KC, Goss L, Kumari S et al. (2001) Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. J Dent Res 80: 1711\u20131715","journal-title":"J Dent Res"},{"key":"1699_CR7","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/1523-1747.ep12292578","volume":"108","author":"Chan","year":"1997","unstructured":"Chan LS, Majmudar AA, Tran HH et al. (1997) Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 108: 848\u2013853","journal-title":"J Invest Dermatol"},{"key":"1699_CR8","first-page":"2283","volume":"40","author":"Chan","year":"1999","unstructured":"Chan RY, Bhol K, Tesavibul N et al. (1999) The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 40: 2283\u20132290","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1699_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archderm.138.3.370","volume":"138","author":"Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ et al. (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138: 370\u2013379","journal-title":"Arch Dermatol"},{"key":"1699_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/clim.2000.4972","volume":"98","author":"Colon","year":"2001","unstructured":"Colon JE, Bhol KC, Razzaque MS et al. (2001) In vitro organ culture model for mucous membrane pemphigoid. Clin Immunol 98: 229\u2013234","journal-title":"Clin Immunol"},{"key":"1699_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1365-2230.2005.01923.x","volume":"30","author":"Coronella","year":"2005","unstructured":"Coronella G, Amato L, Berti S et al. (2005) Ocular \u201anon-scarring\u2018 mucous membrane pemphigoid associated with anti-laminin-5 antibodies. Clin Exp Dermatol 30: 679\u2013681","journal-title":"Clin Exp Dermatol"},{"key":"1699_CR12","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/bjo.2003.039784","volume":"88","author":"Creuzot-Garcher","year":"2004","unstructured":"Creuzot-Garcher C, Xuan TH, Bron AM et al. (2004) Blood group related antigens in ocular cicatricial pemphigoid. Br J Ophthalmol 88: 1247\u20131251","journal-title":"Br J Ophthalmol"},{"key":"1699_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/08820530590931368","volume":"20","author":"Dart","year":"2005","unstructured":"Dart JKG (2005) Cicatricial pemphigoid and dry eye. Semin Ophthalmol 20: 95\u2013100","journal-title":"Semin Ophthalmol"},{"key":"1699_CR14","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","volume":"357","author":"Egan","year":"2001","unstructured":"Egan CA, Lazarova Z, Darling TN et al. (2001) Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 357: 1850\u20131851","journal-title":"Lancet"},{"key":"1699_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000060709","volume":"28","author":"Elder","year":"1997","unstructured":"Elder M, Bernauer W (1997) Monitoring of activity and progression in cicatrising conjunctivitis. In: Bernauer W, Dart JKG, Elder MJ (eds) Cicatrising conjunctivitis. Dev Ophthalmol 28: 111\u2013122","journal-title":"Dev Ophthalmol"},{"key":"1699_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjo.80.4.292","volume":"80","author":"Elder","year":"1996","unstructured":"Elder MJ, Bernauer W, Leonard J et al. (1996) Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 80: 292\u2013296","journal-title":"Br J Ophthalmol"},{"key":"1699_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/01.icu.0000179802.04101.79","volume":"16","author":"Eschle-Meniconi","year":"2005","unstructured":"Eschle-Meniconi ME, Ahmad SR, Foster CS (2005) Mucous membrane pemhigoid: an update. Curr Opin Ophthalmol 16: 303\u2013307","journal-title":"Curr Opin Ophthalmol"},{"key":"1699_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1067\/mjd.2000.107248","volume":"43","author":"Fleming","year":"2000","unstructured":"Fleming TE, Korman NJ (2000) Cicatricial pemphigoid. J Am Acad Dermatol 43: 571\u2013591","journal-title":"J Am Acad Dermatol"},{"key":"1699_CR19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","volume":"89","author":"Foster","year":"1982","unstructured":"Foster CS, Wilson LA, Ekins MB (1982) Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 89: 340\u2013353","journal-title":"Ophthalmology"},{"key":"1699_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00130832-200410000-00017","volume":"4","author":"Foster","year":"2004","unstructured":"Foster CS, Sainz De La Maza M (2004) Ocular cicatricial pemphigoid review. Curr Opin Allergy Clin Immunol 4: 435\u2013439","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1699_CR21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0002-9394(75)90278-0","volume":"80","author":"Furey","year":"1975","unstructured":"Furey N, West C, Andrews T et al. (1975) Immunofluorescent studies of ocular cicatricial pemphigoid. Am J Ophthalmol 80: 825\u2013831","journal-title":"Am J Ophthalmol"},{"key":"1699_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0738-081X(00)00185-1","volume":"19","author":"Guide","year":"2001","unstructured":"Guide SV, Marinkovich MP (2001) Linear IgA bullous dermatosis. Clin Dermatol 19: 719\u2013727","journal-title":"Clin Dermatol"},{"key":"1699_CR23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/eye.1996.94","volume":"10","author":"Heiligenhaus","year":"1996","unstructured":"Heiligenhaus A, Dutt JE, Foster CS (1996) Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva. Eye 10: 425\u2013432","journal-title":"Eye"},{"key":"1699_CR24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1055\/s-2005-858455","volume":"222","author":"Heiligenhaus","year":"2005","unstructured":"Heiligenhaus A, Bonsmann G, Heinz C et al. (2005) Empfehlungen zu Diagnostik und Therapie beim Schleimhautpemphigoid am Auge. Klin Monatsbl Augenheilkd 222: 689\u2013703","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1699_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0161-6420(99)90076-3","volume":"106","author":"Hoang-Xuan","year":"1999","unstructured":"Hoang-Xuan T, Robin H, Demers PE et al. (1999) Pure ocular cicatricial pemphigoid: a distinct immunopathologic subset of cicatricial pemphigoid. Ophthalmology 106: 355\u2013361","journal-title":"Ophthalmology"},{"key":"1699_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/1523-1747.ep12323431","volume":"105","author":"Kirtschig","year":"1995","unstructured":"Kirtschig G, Marinkovich MP, Burgeson RE et al. (1995) Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 105: 543\u2013548","journal-title":"J Invest Dermatol"},{"key":"1699_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1076\/0271-3683(200008)21:2;1-V;FT646","volume":"21","author":"Letko","year":"2000","unstructured":"Letko E, Bhol K, Foster SC et al. (2000) Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study. Curr Eye Res 21: 646\u2013654","journal-title":"Curr Eye Res"},{"key":"1699_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","volume":"135","author":"Leverkus","year":"1999","unstructured":"Leverkus M, Schmidt E, Lazarova Z et al. (1999) Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol 135: 1091\u20131098","journal-title":"Arch Dermatol"},{"key":"1699_CR29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/archderm.135.8.954","volume":"135","author":"Luke","year":"1999","unstructured":"Luke MC, Darling TN, Hsu R et al. (1999) Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol 135: 954\u2013959","journal-title":"Arch Dermatol"},{"key":"1699_CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","volume":"88","author":"Mondino","year":"1981","unstructured":"Mondino BJ, Brown SI (1981) Ocular cicatricial pemphigoid. Ophthalmology 88: 95\u2013100","journal-title":"Ophthalmology"},{"key":"1699_CR31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0002-9394(77)90546-3","volume":"83","author":"Mondino","year":"1977","unstructured":"Mondino BJ, Ross AN, Rabin BS et al. (1977) Autoimmune phenomena in ocular cicatricial pemphigoid. Am J Ophthalmol 83: 443\u2013350","journal-title":"Am J Ophthalmol"},{"key":"1699_CR32","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1365-4632.2006.02750.x","volume":"45","author":"Mulyowa","year":"2006","unstructured":"Mulyowa GK, J\u00e4ger G, Kabakyenga J et al. (2006) Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients. Int J Dermatol 45: 1047\u20131052","journal-title":"Int J Dermatol"},{"key":"1699_CR33","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jaad.2005.03.054","volume":"42","author":"Mulyowa","year":"2006","unstructured":"Mulyowa GK, Jaeger G, Sitaru C et al. (2006) Scarring autoimmune bullous disease in a Ugandan patient with autoantibodies to BP180, BP230, and Laminin 5. J Am Acad Dermatol 42: S43\u2013S46","journal-title":"J Am Acad Dermatol"},{"key":"1699_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0923-1811(97)00067-4","volume":"17","author":"Murakami","year":"1998","unstructured":"Murakami H, Nishioka S, Setterfield J et al. (1998) Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J Dermatol Sci 17: 39\u201344","journal-title":"J Dermatol Sci"},{"key":"1699_CR35","first-page":"1702","volume":"43","author":"Nakamura","year":"2002","unstructured":"Nakamura T, Nishida K, Dota A et al. (2002) Changes in conjunctival clusterin expression in severe ocular surface disease. Invest Ophthalmol Vis Sci 43: 1702\u20137","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1699_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","volume":"154","author":"Oyama","year":"2006","unstructured":"Oyama N, Setterfield JF, Powell AM et al. (2006) Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol 154: 90\u201398","journal-title":"Br J Dermatol"},{"key":"1699_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s003470170125","volume":"98","author":"Pleyer","year":"2001","unstructured":"Pleyer U, M\u00fcller B (2001) Okul\u00e4res vernarbendes Pemphigoid. Ophthalmologe 98: 584\u2013597","journal-title":"Ophthalmologe"},{"key":"1699_CR38","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0161-6420(95)30896-2","volume":"102","author":"Power","year":"1995","unstructured":"Power WJ, Neves RA, Rodriguez A et al. (1995) Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology 102: 1158\u20131163","journal-title":"Ophthalmology"},{"key":"1699_CR39","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","volume":"126","author":"Rashid","year":"2006","unstructured":"Rashid KA, Gurcan HM, Ahmed AR (2006) Antigen specificity in subsets of mucous membrane pemphigoid. J Invest Dermatol 126: 2631\u20132636","journal-title":"J Invest Dermatol"},{"key":"1699_CR40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ophtha.2005.01.039","volume":"112","author":"Rauz","year":"2005","unstructured":"Rauz S, Maddison PG, Dart JKG (2005) Evaluation of mucous membrane pemphigoid with ocular involvement in young patients. Ophthalmology 112: 1268\u20131274","journal-title":"Ophthalmology"},{"key":"1699_CR41","unstructured":"Riederle H, Schmidt E, Eck M et al. (2006) Plattenepithelkarzinom der Bindehaut und okul\u00e4res Schleimhautpemphigoid \u2013 eine neue Assoziation? Poster, 104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft, Berlin, 21.\u201324.09.2006"},{"key":"1699_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.survophthal.2006.06.012","volume":"51","author":"Robinson","year":"2006","unstructured":"Robinson JW, Brownstein S, Jordan DR et al. (2006) Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature. Surv Ophthalmol 51: 513\u2013519","journal-title":"Surv Ophthalmol"},{"key":"1699_CR43","first-page":"113","volume":"16","author":"Schmidt","year":"2000","unstructured":"Schmidt E, Zillikens D (2000) Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory. Adv Dermatol 16: 113\u2013157","journal-title":"Adv Dermatol"},{"key":"1699_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s001050051124","volume":"51","author":"Schmidt","year":"2000","unstructured":"Schmidt E, Br\u00f6cker EB, Zillikens D (2000) Pemphigus: Verlust des desmosomalen Zell-Zell-Zell-Kontaktes. Hautarzt 51: 309\u2013318","journal-title":"Hautarzt"},{"key":"1699_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archderm.136.2.174","volume":"136","author":"Schmidt","year":"2000","unstructured":"Schmidt E, Obe K, Br\u00f6cker EB et al. (2000) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136: 174\u2013178","journal-title":"Arch Dermatol"},{"key":"1699_CR46","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","volume":"145","author":"Schmidt","year":"2001","unstructured":"Schmidt E, Skrobek C, Kromminga A et al. (2001) Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 145: 778\u2013783","journal-title":"Br J Dermatol"},{"key":"1699_CR47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0161-6420(92)32001-9","volume":"99","author":"Schwab","year":"1992","unstructured":"Schwab IR, Linberg JV, Gioia VM et al. (1992) Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology 99: 197\u2013202","journal-title":"Ophthalmology"},{"key":"1699_CR48","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1046\/j.1365-2133.1998.02168.x","volume":"138","author":"Setterfield","year":"1998","unstructured":"Setterfield J, Shirlaw PJ, Kerr-Muir M et al. (1998) Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 138: 602\u2013610","journal-title":"Br J Dermatol"},{"key":"1699_CR49","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1365-2133.1999.02763.x","volume":"140","author":"Setterfield","year":"1999","unstructured":"Setterfield J, Shirlaw PJ, Bhogal BS et al. (1999) Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity. Br J Dermatol 140: 645\u2013650","journal-title":"Br J Dermatol"},{"key":"1699_CR50","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1600-0625.2005.00367.x","volume":"14","author":"Sitaru","year":"2005","unstructured":"Sitaru C, Zillikens D (2005) Mechanisms of blister induction by autoantibodies. Exp Dermatol 14: 861\u2013875","journal-title":"Exp Dermatol"},{"key":"1699_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0161-6420(89)32942-3","volume":"96","author":"Tauber","year":"1989","unstructured":"Tauber J, Melamed S, Foster CS (1989) Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 96: 33\u201337","journal-title":"Ophthalmology"},{"key":"1699_CR52","first-page":"982","volume":"39","author":"Tesavibul","year":"2004","unstructured":"Tesavibul N, Dorfman D, Sangwan VS et al. (2004) Costimulatory molecules in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 39: 982\u2013988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1699_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","volume":"111","author":"Thorne","year":"2004","unstructured":"Thorne JE, Anhalt GJ, Jabs DA (2004) Mucous membrane pemphigoid and pseudopemhpigoid. Ophthalmology 111: 45\u201352","journal-title":"Ophthalmology"},{"key":"1699_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-5945-4-10","volume":"4","author":"Vodegel","year":"2004","unstructured":"Vodegel RM, Jong MC de, Meijer HJ et al. (2004) Enhanced diagnostic immunofluorescence using biopsies transported in saline. BMC Dermatol 4: 10","journal-title":"BMC Dermatol"},{"key":"1699_CR55","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/archderm.139.8.1007","volume":"139","author":"Wozniak","year":"2003","unstructured":"Wozniak K, Kazama T, Kowalewski C (2003) A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy. Arch Dermatol 139: 1007\u201311","journal-title":"Arch Dermatol"},{"key":"1699_CR56","doi-asserted-by":"crossref","unstructured":"Zillikens D (2005) Bull\u00f6se Autoimmundermatosen. In: Braun-Falco O, Plewig G, Wolff HH et al. (Hrsg) Dermatologie, 5. Aufl. Springer, Berlin Heidelberg New York, S 607\u2013638","DOI":"10.1007\/3-540-26624-0_43"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-008-1699-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1699-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:16:07Z","timestamp":1652660167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-008-1699-x"}},"subtitle":["Teil I: Klinik, Pathogenese und Diagnostik","Part I: Clinical manifestations, pathogenesis and diagnosis"],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["1699"],"URL":"https:\/\/doi.org\/10.1007\/s00347-008-1699-x","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"13 March 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}